Navigation Links
Freiburg scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
Date:3/14/2014

This news release is available in German.

This news release is available in German.

Michael Reth has won the Paul Ehrlich and Ludwig Darmstaedter Prize, awarded by the Paul Ehrlich Foundation, for his research on the immune system. For the first time since 1996, the prize goes to a scientist working in Germany. Reth is Professor for Molecular Immunology at the Institute of Biology III of the University of Freiburg and Scientific Director of the Cluster of Excellence BIOSS, Centre for Biological Signalling Studies. He is also head of the department for Molecular Immunology at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE). The prize is endowed with 100,000 and is one of the highest honours in science in Germany. By awarding the prize to Reth, the Foundation has chosen to honour a scientist who, like Nobel laureate Paul Ehrlich, decodes how immunity operates at a molecular level, in order to find new therapies for cancer and infectious diseases.

"This award is a great honour for me, because I deeply admire Paul Ehrlich's work in immunology," Reth said. "He was one of the first scientists to consider the molecular level in this field." Following Ehrlich's scientific tradition, Reth chose to focus his research on how the human body recognises foreign substances.

"Due to the success of vaccinations, which was one of the greatest achievements in medicine, immunology has been an applied science from the beginning. However, we still do not fully understand the processes that underlie immunisation," Reth remarks. That is why his research revolves around the B cell component of the immune system. When activated, these blood cells produce antibodies to fight off infection. Reth investigates the structure and organisation of the B cell antigen receptors. These molecules on the surface of B cells recognise foreign substances, so-called antigens, and trigger the activation of the immune system. Reth was able to describe the basic structure of the antigen receptor of B cells for the first time in 1989. Together with his research group, he developed a new model for the activation of this receptor and recently provided further experimental evidence for this model.

Furthermore Reth has shown that receptors on the plasma membrane have a more complex structure than previously assumed. They are not freely diffusing on the cell surface but are organized in 50 to 150 nanometre sized membrane patches also called protein islands.

Reth is the third researcher from the Max Planck Institute of Immunobiology and Epigenetics to be awarded the Paul Ehrlich and Ludwig Darmstaedter Prize. Otto Lderitz (who won the prize in 1965) and Otto Westphal (who won in 1968), both directors at the Max Planck Institute in Freiburg, also received the award for their work on the structure and effect of bacterial toxins, or so-called lipopolysaccharides.


'/>"/>

Contact: Dr. Michael Reth
michael.reth@bioss.uni-freiburg.de
49-761-510-8420
Max-Planck-Gesellschaft
Source:Eurekalert  

Related biology news :

1. Plant biology discovery furthers scientists understanding of plant growth and development
2. Tropical grassy ecosystems under threat, scientists warn
3. Scientists herd cells in new approach to tissue engineering
4. Geoscientists to meet in Fayetteville to discuss triggered seismicity, karst & energy resources
5. SURA honors Georgia Tech biologist as Distinguished Scientist
6. Scientists discover the specific types of macrophages that affect Crohns disease severity
7. Scientists to tackle burden of cattle disease on UK farms
8. Scientists highlight the importance of nutrients for coral reefs
9. Scientists learn how pathogens hack our immune systems to go undetected
10. NPL scientists blend synthetic air to measure climate change
11. Southern insect scientists meeting in Greenville, S.C.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Freiburg scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
(Date:2/9/2016)... Mass., Feb. 9, 2016 Aware, Inc. (NASDAQ: AWRE ... financial results for its fourth quarter and year ended December 31, ... for the fourth quarter of 2015 was $6.9 million, an increase ... year. Operating income in the fourth quarter of 2015 was $2.6 ... --> --> Higher revenue ...
(Date:2/4/2016)... , Feb. 4, 2016 The ... apparently one of the most popular hubs of ... MetaHIT and other huge studies of human microbiota, ... past few years, the microbiome space has literally ... biomedical research. This report focuses on biomedical ...
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... CRUZ, Calif. , Feb. 11, 2016  Dovetail ... applications to its beta program for a planned metagenomic ... will present the company,s metagenomic genome assembly method in ... Advances in Genome Biology & Technology conference in ... assembly of these highly complex datasets is difficult. Using ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem Cells ... in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques ... the world. , The new GSCG clinic is headed by four prominent ...
(Date:2/10/2016)... is introducing a hybrid membership model which will provide ... joining or renewing through an organizational purchasing model. For ... employee in any size association or AMC office can ... benefits.   John H. Graham, IV , ... organizations of any size and their employees to gain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a fully-integrated network ... two long-standing principal investigators (PI) to the roles of Chief Medical Officer, Clinical ... Dr. Laurence Chu, a Benchmark Research PI in the Austin office, will assume ...
Breaking Biology Technology: